Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer
- PMID: 31856087
- DOI: 10.1097/MPA.0000000000001464
Pancreatic Stellate Cells Promote Tumor Progression by Promoting an Immunosuppressive Microenvironment in Murine Models of Pancreatic Cancer
Abstract
Objectives: Pancreatic ductal adenocarcinoma (PDAC) is one of the most lethal forms of cancer with poor prognosis. Pancreatic stellate cells (PSCs) play a vital role in PDAC development. The aim of this study was to explore tumor microenvironment response to PSCs in an orthotopic pancreatic cancer mouse model and to assess if PSCs secreted factors that can facilitate an immunosuppressive microenvironment.
Methods: Pancreatic ductal adenocarcinoma orthotopic tumor model, derived from coinjection of Panc02 cells plus PSCs, was used to investigate tumor proliferation, metastasis, and the population of immune cells in vivo, including regulatory T cells, M2-type macrophages, myeloid-derived suppressor cells, CD8 T cells, CD4 T cells, M1-type macrophages, natural killer (NK), and NK T cells.
Results: Pancreatic stellate cells promoted PDAC growth not only induced cell proliferation and metastasis, but also significantly increased the suppressive immune cell population of regulatory T cells, M2-type macrophages, and myeloid-derived suppressor cells. In addition, PSCs decreased the immune cell population of CD8 T, CD4 T cells, and M1-type macrophages in the spleen and tumor tissues of the tumor-bearing mice. Moreover, PSCs decreased the population of NK and NK T cells in the tumor tissues.
Conclusions: Our findings support PSCs playing multiple roles in PDAC development via promoting immunosuppressive microenvironment.
Similar articles
-
The role of 2-arachidonoylglycerol in the regulation of the tumor-immune microenvironment in murine models of pancreatic cancer.Biomed Pharmacother. 2019 Jul;115:108952. doi: 10.1016/j.biopha.2019.108952. Epub 2019 May 9. Biomed Pharmacother. 2019. PMID: 31078044
-
PLXDC1+ Tumor-Associated Pancreatic Stellate Cells Promote Desmoplastic and Immunosuppressive Niche in Pancreatic Ductal Adenocarcinoma.Adv Sci (Weinh). 2025 May;12(18):e2415756. doi: 10.1002/advs.202415756. Epub 2025 Mar 17. Adv Sci (Weinh). 2025. PMID: 40091495 Free PMC article.
-
Galectin-3 Mediates Tumor Cell-Stroma Interactions by Activating Pancreatic Stellate Cells to Produce Cytokines via Integrin Signaling.Gastroenterology. 2018 Apr;154(5):1524-1537.e6. doi: 10.1053/j.gastro.2017.12.014. Epub 2017 Dec 21. Gastroenterology. 2018. PMID: 29274868
-
The critical roles of activated stellate cells-mediated paracrine signaling, metabolism and onco-immunology in pancreatic ductal adenocarcinoma.Mol Cancer. 2018 Feb 19;17(1):62. doi: 10.1186/s12943-018-0815-z. Mol Cancer. 2018. PMID: 29458370 Free PMC article. Review.
-
Persistent activation of pancreatic stellate cells creates a microenvironment favorable for the malignant behavior of pancreatic ductal adenocarcinoma.Int J Cancer. 2013 Mar 1;132(5):993-1003. doi: 10.1002/ijc.27715. Epub 2012 Oct 5. Int J Cancer. 2013. PMID: 22777597 Review.
Cited by
-
T cells in pancreatic cancer stroma.World J Gastroenterol. 2021 Dec 14;27(46):7956-7968. doi: 10.3748/wjg.v27.i46.7956. World J Gastroenterol. 2021. PMID: 35046623 Free PMC article. Review.
-
Natural killer cells in pancreatic cancer stroma.World J Gastroenterol. 2021 Jun 28;27(24):3483-3501. doi: 10.3748/wjg.v27.i24.3483. World J Gastroenterol. 2021. PMID: 34239264 Free PMC article. Review.
-
Pancreatic stellate cells in pancreatic cancer: as potential targets for future therapy.Front Oncol. 2023 Jun 20;13:1185093. doi: 10.3389/fonc.2023.1185093. eCollection 2023. Front Oncol. 2023. PMID: 37409257 Free PMC article. Review.
-
Characterization of 3D heterocellular spheroids of pancreatic ductal adenocarcinoma for the study of cell interactions in the tumor immune microenvironment.Front Oncol. 2023 Jul 14;13:1156769. doi: 10.3389/fonc.2023.1156769. eCollection 2023. Front Oncol. 2023. PMID: 37519820 Free PMC article.
-
Exosomal microRNA in Pancreatic Cancer Diagnosis, Prognosis, and Treatment: From Bench to Bedside.Cancers (Basel). 2021 Jun 3;13(11):2777. doi: 10.3390/cancers13112777. Cancers (Basel). 2021. PMID: 34204940 Free PMC article. Review.
References
-
- Ryan DP, Hong TS, Bardeesy N. Pancreatic adenocarcinoma. N Engl J Med. 2014;371:2140–2141.
-
- Siegel RL, Miller KD, Jemal A. Cancer statistics, 2017. CA Cancer J Clin. 2017;67:7–30.
-
- Chronopoulos A, Robinson B, Sarper M, et al. ATRA mechanically reprograms pancreatic stellate cells to suppress matrix remodeling and inhibit cancer cell invasion. Nat Commun. 2016;7:12630.
-
- Chen ML, Pittet MJ, Gorelik L, et al. Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc Natl Acad Sci U S A. 2005;102:419–424.
-
- Ene-Obong A, Clear AJ, Watt J, et al. Activated pancreatic stellate cells sequester CD8+ T cells to reduce their infiltration of the juxtatumoral compartment of pancreatic ductal adenocarcinoma. Gastroenterology. 2013;145:1121–1132.
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Research Materials